login

A study on coverage, compliance and awareness about mass drug administration for elimination of lymphatic filariasis in a district of West Bengal, India.

PubMedPublished 1 June 2011
Pritikana Karmakar, Keya Mitra, Anirban Chatterjee, Pulak Kumar Jana, S Bhattacharya, S. Lahiri
Citations35

TL;DR

More than 40 million people suffer from the stigmatizing and disabling clinical manifestations of the disease, including 15 million who have lymphoedema (elephantiasis) and 25million men who have urogenital swelling, principally scro-tal hydrocele.

Abstract

Lymphatic Filariasis (LF) is one of the oldest and mostdebilitating neglected tropical diseases (NTDs). An esti-mated 120 million people in 81 countries are infected cur-rently, and an estimated 1.34 billion live in areas wherefilariasis is endemic and are at risk of infection. Approxi-mately 40 million people suffer from the stigmatizing anddisabling clinical manifestations of the disease, including15 million who have lymphoedema (elephantiasis) and 25million men who have urogenital swelling, principally scro-tal hydrocele

Keywords

Immunology and MicrobiologyMedicineEnvironmental Science